Viewing StudyNCT01364493



Ignite Creation Date: 2024-05-05 @ 11:36 PM
Last Modification Date: 2024-10-26 @ 10:36 AM
Study NCT ID: NCT01364493
Status: COMPLETED
Last Update Posted: 2017-05-09
First Post: 2011-05-31

Brief Title: A Study to Evaluate the Efficacy and Safety of Trastuzumab in Combination With Capecitabine and Oxaliplatin as First-line Chemotherapy for Inoperable Locally Advanced or Recurrent andor Metastatic Gastric Cancer
Sponsor: Peking University
Organization: Peking University

Conditions & Keywords Data

Conditions:
Name
Gastric Cancer
Keywords:
Name View
metastatic View
HER2-positive View
adenocarcinoma of the stomach or gastro-esophageal junction View
Inoperable View
locally advanced View
recurrent View